|
FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary ...
RARITAN, N.J., May 23, 2012 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee ...
finance.yahoo.com
Orchestrating drug management (American College of Physicians annual scientific meeting)
Managing medications is becoming more complicated due to the aging population, use of opioids for chronic pain and increased FDA drug safety messages.
www.ama-assn.org
Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of ...
RARITAN, N.J., May 2, 2012 /PRNewswire/ -- Janssen Research & Development, LLC, (Janssen), announced today that it has submitted supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration ...
ca.finance.yahoo.com
Janssen Research & Development Submits Supplemental New Drug Application to U.S. FDA for XARELTO® (rivaroxaban) to ...
RARITAN, N.J., May 9, 2012 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration ...
ca.finance.yahoo.com
Recent Studies Conclude That Acupuncture Will End Your Relationship with Painkillers
Remedy Acupuncture Clinic in San Francisco is Specializing in Post-Surgery Pain Management, and Eliminating the Need for Long-Term Pain Medication.San Francisco, CA (PRWEB) May 01, 2012 Acupuncture is emerging into a widely accepted method for pain management. Many recent studies conclude that acupuncture for post-surgery pain control is very valuable. ...
news.yahoo.com
|
